ALTHEA ANDRADE: Open Payments
NPI 1568084267 · MIAMI GARDENS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,735 in 128 payments from 11 companies in 2025. Trend: 2023 $198 · 2024 $1,925 · 2025 $2,735
Food & beverage: $2,730Education: $5
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $639 |
| ABBVIE INC. | 43 | $579 |
| Teva Pharmaceuticals USA, Inc. | 29 | $571 |
| Neurocrine BioSciences, Inc. | 11 | $283 |
| E.R. Squibb & Sons, L.L.C. | 7 | $228 |
| Janssen Pharmaceuticals, Inc | 11 | $184 |
| Alkermes, Inc. | 7 | $117 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Lundbeck LLC | 2 | $28 |
Products named: CAPLYTA, VRAYLAR, UZEDY, INGREZZA, AUSTEDO XR, COBENFY, INVEGA SUSTENNA, ARISTADA.
Industry payments across FL — which companies pay providers there.
